Updated 10/30/2008 - As always, this model is a work in progress, see the accompanying blog post for further details and discussion.
| Q407 act | Q108 est | Q108 act | est vs act Q1 | Q208 est | Q208 act | est vs act Q2 | Q308 est | est vs act 08 | est vs act Q3 | Q408 est | Q408 act | est vs act Q4 | FY08 est | FY08 act | est vs act 08 | |||||||||||
| existing cns revs | 752 | 781 | 774 | -7 | 774 | 765 | -9 | 779 | 779 | 0 | 791 | 791 | 0 | 3125 | 3109 | -16 | ||||||||||
| cns growth revs | 29 | 17 | 0 | -17 | 15 | 14 | -1 | 20 | 12 | -8 | 12 | 12 | 0 | 65 | 38 | -27 | ||||||||||
| existing wvs revs | 150 | 150 | 150 | 0 | 150 | 150 | 0 | 175 | 173 | -2 | 190 | 190 | 0 | 665 | 663 | -2 | ||||||||||
| wvs growth revs | 22 | 5 | 34 | 29 | 35 | 25 | -10 | 0 | 0 | 0 | 0 | 0 | 0 | 40 | 59 | 19 | ||||||||||
| vvyx sale / defr's etc. | 0 | 0 | 0 | 0 | -4 | 18 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 18 | 22 | ||||||||||
| termination revs | 2 | 2 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | -2 | ||||||||||
| core revs | 955 | 955 | 958 | 3 | 970 | 972 | 2 | 974 | 964 | -10 | 993 | 993 | 0 | 3893 | 3887 | -6 | ||||||||||
| other revs | 56 | 50 | 51 | 1 | 44 | 46 | 2 | 90 | 90 | 0 | 81 | 81 | 0 | 265 | 268 | 3 | ||||||||||
| sbc revs | 73 | 40 | 57 | 17 | 40 | 54 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 80 | 111 | 31 | ||||||||||
| com revs | 1084 | 1045 | 1066 | 21 | 1055 | 1072 | 17 | 1064 | 1054 | -10 | 1074 | 1074 | 0 | 4238 | 4266 | 28 | ||||||||||
| com cogs | -444 | -424 | -459 | -35 | -430 | -442 | -12 | -426 | -425 | 1 | -437 | -437 | 0 | -1717 | -1763 | -46 | ||||||||||
| existing cns gp | 480 | 502 | 498 | -4 | 490 | 484 | -6 | 510 | 507 | -3 | 517 | 517 | 0 | 2019 | 2006 | -13 | ||||||||||
| cns growth gp | 22 | 13 | 0 | -13 | 12 | 11 | -1 | 16 | 10 | -6 | 10 | 10 | 0 | 52 | 30 | -21 | ||||||||||
| improvement in cns gp (integreation) | 0 | 0 | -8 | -8 | 7 | 14 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 6 | -1 | ||||||||||
| existing wvs gp | 45 | 45 | 45 | 0 | 45 | 45 | 0 | 53 | 52 | -1 | 57 | 57 | 0 | 200 | 199 | -1 | ||||||||||
| wvs growth gp | 7 | 2 | 10 | 8 | 11 | 8 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 18 | 6 | ||||||||||
| termination gp | 2 | 2 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | -2 | ||||||||||
| other gp | 45 | 40 | 41 | 1 | 40 | 41 | 1 | 60 | 60 | 0 | 54 | 54 | 0 | 194 | 196 | 2 | ||||||||||
| sbc gp | 39 | 17 | 21 | 4 | 20 | 27 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 37 | 48 | 11 | ||||||||||
| com gp | 640 | 621 | 607 | -14 | 625 | 630 | 5 | 638 | 629 | -10 | 637 | 637 | 0 | 2521 | 2503 | -18 | ||||||||||
| com cash sga | -389 | -400 | -395 | 5 | -375 | -373 | 2 | -373 | -370 | 3 | -358 | -358 | 0 | -1506 | -1496 | 10 | ||||||||||
| com ebitdas | 251 | 221 | 212 | -9 | 250 | 257 | 7 | 265 | 259 | -7 | 279 | 279 | 0 | 1015 | 1007 | -8 | ||||||||||
| com ebitdas adj (restruct etc) | -5 | -7 | -7 | 0 | -4 | -4 | 0 | -4 | -2 | 2 | -2 | -2 | 0 | -17 | -15 | 2 | ||||||||||
| coal/other ebitdas | 0 | 6 | 6 | 0 | 4 | -2 | -6 | 4 | -2 | -6 | 3 | 3 | 0 | 17 | 5 | -12 | ||||||||||
| consol ebitdas | 246 | 220 | 211 | -9 | 250 | 251 | 1 | 265 | 255 | -11 | 280 | 280 | 0 | 1015 | 997 | -18 | ||||||||||
| interest, net | -105 | -145 | -129 | 16 | -123 | -128 | -5 | -129 | -129 | 0 | -129 | -129 | 0 | -526 | -515 | 11 | ||||||||||
| cf operating (wc etc) | 53 | -50 | -129 | -79 | -100 | -15 | 85 | 29 | -9 | -38 | 100 | 100 | 0 | -21 | -53 | -32 | ||||||||||
| cf investing (capx etc) | -153 | -145 | -111 | 34 | -127 | -104 | 23 | -125 | -126 | -1 | -129 | -129 | 0 | -526 | -470 | 56 | ||||||||||
| adjustment | 0 | 0 | -2 | -2 | 0 | 0 | 0 | 0 | 5 | 5 | 0 | 0 | 0 | 0 | 3 | 3 | ||||||||||
| free cash flow | 41 | -120 | -160 | -40 | -100 | 4 | 105 | 40 | -4 | -45 | 122 | 122 | 0 | -58 | -38 | 20 | ||||||||||
| cf financing (debt etc) + vvyx | -138 | -25 | -23 | 2 | 130 | 120 | -10 | 0 | -68 | -68 | 0 | 0 | 0 | 105 | 29 | -76 | ||||||||||
| adjustment | 0 | 0 | 2 | 2 | 0 | 4 | 4 | 0 | -7 | -7 | 0 | 0 | 0 | 0 | -1 | -1 | ||||||||||
| change in cash | -97 | -145 | -181 | -36 | 30 | 128 | 99 | 40 | -79 | -120 | 122 | 122 | 0 | 47 | -10 | -57 | ||||||||||
| existing cns gp/existing cns revs | 63.83% | 64.34% | 64.34% |
|
63.31% | 63.31% |
|
65.40% | 65.08% |
|
65.31% | 65.31% | 0.00% | 64.59% | 64.52% | -0.08% | ||||||||||
| cns all gp/cns all revs | 64.34% | 64.62% | 63.31% | -1.31% | 64.52% | 65.40% | 0.88% | 65.78% | 65.31% | -0.47% | 65.53% | 65.53% | 0.00% | 65.11% | 64.90% | -0.22% | ||||||||||
| core gp/core revs | 58.23% | 59.08% | 56.91% | -2.17% | 58.21% | 57.82% | -0.39% | 59.35% | 58.97% | -0.38% | 58.73% | 58.73% | 0.00% | 58.82% | 58.11% | -0.71% | ||||||||||
| com gp/com revs | 59.00% | 59.42% | 56.94% | -2.48% | 59.23% | 58.81% | -0.43% | 59.97% | 59.63% | -0.34% | 59.33% | 59.33% | 0.00% | 59.49% | 58.68% | -0.81% | ||||||||||
| com cash sga/com revs | 35.89% | 38.28% | 37.05% | 1.22% | 35.55% | 34.79% | 0.76% | 35.04% | 35.10% | -0.06% | 33.33% | 33.33% | 0.00% | 35.53% | 35.07% | 0.47% | ||||||||||
| com ebitdas/com revs | 23.11% | 21.14% | 19.89% | -1.26% | 23.68% | 24.01% | 0.33% | 24.93% | 24.53% | -0.40% | 26.00% | 26.00% | 0.00% | 23.96% | 23.61% | -0.35% | ||||||||||
| capex/com revs | 14.11% | 13.88% | 10.41% | 3.46% | 12.04% | 9.70% | 2.34% | 11.74% | 11.95% | -0.21% | 12.01% | 12.01% | 0.00% | 12.41% | 11.02% | 1.39% | ||||||||||
| boxed relationship | -1.03% | 2.10% | -0.09% | 0.22% | 0.30% | |||||||||||||||||||||